PEDIATRICS Vol. 102 No. 6 December 1998, pp. 1369-1375
Clinical Characteristics and Outcome of Children With Pneumonia Attributable to Penicillin-susceptible and Penicillin-nonsusceptible Streptococcus pneumoniae
Received Dec 17, 1997; accepted May 13, 1998.
,
,,
From the Pediatric Infectious Disease Sections of * Northwestern
University Medical School, Chicago, Illinois; Baylor College of
Medicine, Houston, Texas; § Ohio State University College of Medicine,
Columbus Ohio; University of Pittsburgh School of Medicine,
Pittsburgh, Pennsylvania; ¶ University of Arkansas for Medical
Sciences, Little Rock, Arkansas; # Children's Hospital of San Diego and
the University of California-San Diego School of Medicine, San Diego,
California; ** University of Southern California School of Medicine, Los
Angeles, California; and Bowman Gray School of Medicine of Wake
Forest University, Winston-Salem, North Carolina.
Objective. To compare the clinical characteristics, treatment, and outcome of pediatric patients with pneumonia attributable to isolates of Streptococcus pneumoniae that were either susceptible or nonsusceptible to penicillin.
Design. Multicenter, retrospective study.
Setting. Eight children's hospitals in the United States.
Participants. Two hundred fifty-four children with pneumococcal pneumonia identified from patients enrolled in the United States Pediatric Multicenter Pneumococcal Surveillance Study during the 3-year period from September 1, 1993 to August 31, 1996.
Outcome Measures. Demographic and clinical variables including necessity for and duration of hospitalization, frequency of chest tube placement, antimicrobial therapy, susceptibility of isolates, and clinical outcome.
Results. There were 257 episodes of pneumococcal pneumonia that occurred in 254 patients. Of the 257 isolates, 22 (9%) were intermediate and 14 (6%) were resistant to penicillin; 7 (3%) were intermediate to ceftriaxone and 5 (2%) were resistant to ceftriaxone. There were no differences noted in the clinical presentation of the patients with susceptible versus nonsusceptible isolates. Twenty-nine percent of the patients had a pleural effusion. The 189 (74%) hospitalized patients were more likely to have an underlying illness, multiple lung lobe involvement, and the presence of a pleural effusion than nonhospitalized patients. Fifty-two of 72 hospitalized patients with pleural effusions had a chest tube placed, and 27 subsequently underwent a decortication drainage procedure. Eighty percent of the patients treated as outpatients and 48% of the inpatients received a parenteral second or third generation cephalosporin followed by a course of an oral antimicrobial agent. Two hundred forty-eight of the patients (97.6%) had a good response to therapy. Six patients died; however, only 1 of the deaths was related to the pneumococcal infection.
Conclusion. The clinical presentation and outcome of
therapy did not differ significantly between patients with
penicillin-susceptible versus those with nonsusceptible isolates of
S pneumoniae. Hospitalized patients were more likely to
have underlying illnesses, multiple lobe involvement, and the presence
of pleural effusions than patients who did not require hospitalization.
In otherwise normal patients with pneumonia attributable to
penicillin-resistant pneumococcal isolates, therapy with standard
-lactam agents is effective.
Key words:
pediatrics,
pneumococcal pneumonia,
penicillin-resistance.
CiteULike 
Connotea 
Del.icio.us 
Digg 
Facebook 
Reddit 
Technorati 
Twitter What's this?
This article has been cited by other articles:
|
|
 |
|
  S. I. Pelton and M. R. Hammerschlag Overcoming Current Obstacles in the Management of Bacterial Community-Acquired Pneumonia in Ambulatory Children Clinical Pediatrics, January 1, 2005; 44(1): 1 - 17. [PDF]
|
|
|
|
|
|
W. Sakran, L. Valinsky, A. Koren, N. Bor, R. Yishai, and R. Colodner Early Onset of Neonatal Streptococcus pneumoniae Bacteremia and Septic Arthritis Clinical Pediatrics, July 1, 2004; 43(6): 579 - 581. [PDF]
|
|
|
|
 |
|
 H. Bauchner and R. E. Besser Promoting the Appropriate Use of Oral Antibiotics: There Is Some Very Good News Pediatrics, March 1, 2003; 111(3): 668 - 670. [Full Text] [PDF]
|
|
|
|
 |
|
 D. Croisier, P. Chavanet, C. Lequeu, A. Ahanou, A. Nierlich, C. Neuwirth, L. Piroth, M. Duong, M. Buisson, and H. Portier Efficacy and pharmacodynamics of simulated human-like treatment with levofloxacin on experimental pneumonia induced with penicillin-resistant pneumococci with various susceptibilities to fluoroquinolones J. Antimicrob. Chemother., September 1, 2002; 50(3): 349 - 360. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P McMaster, P McIntyre, R Gilmour, L Gilbert, A Kakakios, and C Mellis The emergence of resistant pneumococcal meningitis--implications for empiric therapy Arch. Dis. Child., September 1, 2002; 87(3): 207 - 210. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Q. Tan, E. O. Mason Jr, E. R. Wald, W. J. Barson, G. E. Schutze, J. S. Bradley, L. B. Givner, R. Yogev, K. S. Kim, and S. L. Kaplan Clinical Characteristics of Children With Complicated Pneumonia Caused by Streptococcus pneumoniae Pediatrics, July 1, 2002; 110(1): 1 - 6. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 British Thoracic Society of Standards of Care Comm BTS Guidelines for the Management of Community Acquired Pneumonia in Childhood Thorax, May 1, 2002; 57(90001): i1 - 24. [Full Text] [PDF]
|
|
|
|
 |
|
 P T Heath and A S Breathnach Treatment of infections due to resistant organisms: Childhood respiratory infections Br. Med. Bull., March 1, 2002; 61(1): 231 - 245. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Esposito, F. Blasi, F. Bellini, L. Allegra, and N. Principi Mycoplasma pneumoniae and Chlamydia pneumoniae infections in children with pneumonia Eur. Respir. J., February 1, 2001; 17(2): 241 - 245. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Penicillin Susceptibility and Outcome of Pneumococcal Pneumonia Journal Watch Emergency Medicine, February 1, 1999; 1999(201): 12 - 12. [Full Text]
|
|
